Yang Shi

3.6k total citations · 1 hit paper
63 papers, 2.7k citations indexed

About

Yang Shi is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yang Shi has authored 63 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Cardiology and Cardiovascular Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yang Shi's work include Lung Cancer Treatments and Mutations (7 papers), Vitamin D Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Yang Shi is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Vitamin D Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Yang Shi collaborates with scholars based in China, United States and United Kingdom. Yang Shi's co-authors include Jian Hua Shi, Yi‐Long Wu, Kye Young Lee, Mei Hou, Shun Lü, Sarayut Lucien Geater, Wěi Li, Chengping Hu, Dan Massey and Yunchao Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yang Shi

61 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

2014 1.6k citations Yi‐Long Wu, Caicun Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yang Shi China	22	1.6k	1.5k	696	386	297	63	2.7k
Tsung‐Ying Yang Taiwan	27	814 0.5×	828 0.6×	682 1.0×	285 0.7×	102 0.3×	88	1.9k
Christopher D. Coldren United States	24	1.1k 0.7×	653 0.4×	1.3k 1.8×	485 1.3×	119 0.4×	36	2.7k
Michelle Wilson United Kingdom	5	358 0.2×	839 0.6×	455 0.7×	695 1.8×	449 1.5×	7	2.4k
Shiu‐Ru Lin Taiwan	32	485 0.3×	1.1k 0.8×	1.1k 1.5×	818 2.1×	119 0.4×	105	2.7k
Emma H. Allott United States	22	771 0.5×	651 0.4×	526 0.8×	1.0k 2.7×	89 0.3×	69	2.1k
Hung‐Ming Lam United States	24	766 0.5×	770 0.5×	1.1k 1.6×	494 1.3×	190 0.6×	57	2.5k
Qiao Li China	25	542 0.3×	966 0.7×	667 1.0×	778 2.0×	133 0.4×	152	2.1k
Yoshihisa Umekita Japan	26	528 0.3×	1.0k 0.7×	797 1.1×	777 2.0×	75 0.3×	133	2.7k
Klaus Baumann Germany	22	421 0.3×	1.0k 0.7×	378 0.5×	247 0.6×	77 0.3×	84	2.2k
Yoshihiko Ueda Japan	28	521 0.3×	361 0.2×	912 1.3×	198 0.5×	257 0.9×	150	2.9k

Countries citing papers authored by Yang Shi

Since Specialization

Citations

This map shows the geographic impact of Yang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Shi more than expected).

Fields of papers citing papers by Yang Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Shi. The network helps show where Yang Shi may publish in the future.

Co-authorship network of co-authors of Yang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Shi. A scholar is included among the top collaborators of Yang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Shi. Yang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Jiahong, Satoshi Ogasawara, Ran Liu, et al.. (2025). LBA2 TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization (TACE) combined with atezolizumab + bevacizumab (Atezo+Bev) or on-demand TACE alone in patients with systemically untreated, intermediate-to-high burden unresectable hepatocellular carcinoma (uHCC). Annals of Oncology. 36. S62–S62. 1 indexed citations

Feng, Jing, Run Xu, Yutong Hao, et al.. (2025). Tetrahydroberberrubine improves hyperlipidemia by activating the AMPK/SREBP2/PCSK9/LDL receptor signaling pathway. European Journal of Pharmacology. 989. 177228–177228. 2 indexed citations

Li, Xing, et al.. (2025). The Impact of Type, Dose, and Duration of Prebiopsy Corticosteroids Use on Histomorphology and Immunohistochemical Stains in B-Cell Lymphoma: A Case-Control Study to Highlight the “Atypical” Cytoplasmic and Extra-Cellular Granular Staining Pattern of CD20. Applied immunohistochemistry & molecular morphology. 33(3). 164–169.

Tang, Xueqing, Yang Shi, Pingping Tang, et al.. (2024). Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1α-mediated thermogenesis in white and brown adipose tissue. Biochemical Pharmacology. 226. 116381–116381. 2 indexed citations

Shi, Yang, Ling Liu, Chen Chen, et al.. (2023). Pharmacodynamics of frigid zone plant Taxus cuspidata S. et Z. against skin melanin deposition, oxidation, inflammation and allergy. SHILAP Revista de lepidopterología. 3(1). 42–52. 1 indexed citations

Gong, Hongli, Song Tian, Lei Tao, et al.. (2023). 934P Antitumor activity and safety profile of camrelizumab plus docetaxel, cisplatin, and capecitabine for induction therapy in advanced stage hypopharyngeal carcinoma. Annals of Oncology. 34. S588–S588. 1 indexed citations

Wu, Wei, et al.. (2022). Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma. Volume 9. 537–551. 8 indexed citations

Wang, Kang, Jiazheng Sun, Yongfu Xiong, et al.. (2020). Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study. npj Breast Cancer. 6(1). 36–36. 38 indexed citations

Li, Zhen, Kun Ji, Liangliang Bai, et al.. (2020). A novel application of drug-eluting transarterial chemoembolization in treating non-liver cancers. Medicine. 99(31). e20878–e20878. 2 indexed citations

10.

Wang, Mengqiao, et al.. (2019). A genome-wide association study on photic sneeze reflex in the Chinese population. Scientific Reports. 9(1). 4993–4993. 1 indexed citations

11.

Wang, Haijun, et al.. (2018). The prognostic values of beta-2 microglobulin for risks of cardiovascular events and mortality in the elderly patients with isolated systolic hypertension. Journal of Research in Medical Sciences. 23(1). 82–82. 11 indexed citations

12.

Liu, Hao, Xiaoping Zhao, Buchang Zhao, et al.. (2018). Screening and Identification of Cardioprotective Compounds From Wenxin Keli by Activity Index Approach and in vivo Zebrafish Model. Frontiers in Pharmacology. 9. 1288–1288. 18 indexed citations

13.

Frietze, Kathryn M., Richard B.S. Roden, Ji‐Hyun Lee, et al.. (2015). Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence–Coupled Biopanning Platform. Cancer Immunology Research. 4(2). 157–164. 21 indexed citations

14.

Geater, Sarayut Lucien, Chong‐Rui Xu, Caicun Zhou, et al.. (2015). Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non–small-cell Lung Cancer. Journal of Thoracic Oncology. 10(6). 883–889. 49 indexed citations

15.

He, Zuping, Ruhui Tian, Yang Shi, et al.. (2015). NODAL secreted by male germ cells regulates the proliferation and function of human Sertoli cells from obstructive azoospermia and nonobstructive azoospermia patients. Asian Journal of Andrology. 17(6). 996–996. 9 indexed citations

16.

Schlosshauer, Bürkhard, Stefan Liebler, Fritz Grunert, et al.. (2014). Session VI – In vitro-Testung/Tissue Engineering (V38-V43). 15(Supplement). 1 indexed citations

17.

Chen, Wei Ren, et al.. (2014). Vitamin D, Parathyroid Hormone, and Serum Lipid Profiles in a Middle-Aged and Elderly Chinese Population. Endocrine Practice. 20(6). 556–565. 5 indexed citations

18.

Chen, Wei Ren, et al.. (2013). Relation of Low Vitamin D to Nonvalvular Persistent Atrial Fibrillation in Chinese Patients. Annals of Noninvasive Electrocardiology. 19(2). 166–173. 50 indexed citations

19.

Liu, Jianfang, Zhenzhen Zhang, Yang Liu, et al.. (2012). Generation, Characterization, and Potential Therapeutic Applications of Cardiomyocytes from Various Stem Cells. Stem Cells and Development. 21(12). 2095–2110. 22 indexed citations

20.

Cai, Haibo, et al.. (2008). Comparison between the effects of normoxia and hypoxia on antioxidant enzymes and glutathione redox state in ex vivo culture of CD34+ cells. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 151(2). 153–158. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact